Study from Hu et al. revealed that down-regulation of ANRIL could decrease nasopharyngeal carcinoma cells proliferation, induce apoptosis, and enhance radio-sensitivity by mediation of miR-125a [33]. This evidence concerns the gene CDKN2B-AS1 and nasopharyngeal carcinoma.